CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Since NKG2A was associated with the effectiveness of dasatinib, we probed the potential role of NKG2A-HLA-E interaction by first examining the levels of HLA-E in CD34+ HSCs isolated from healthy adults and from treatment-naive CML patients.